2009
In 21 people with Parkinson's, IV glutathione (into a vein) 1,400 mg three times a week for 4 weeks was well tolerated with no safety concerns. Scores for movement and daily living improved by a mean of 2.8 units more than placebo, but the difference was not statistically significant (P=0.32), meaning it could be chance.
Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D
2015
In 54 non-smoking adults, glutathione by mouth (250 or 1,000 mg/day for 6 months) raised the body's glutathione stores in a dose-dependent way (a higher dose raised them more): about 30–35% in blood compartments and 260% in cheek cells at the high dose. Natural killer cell activity (a type of immune cell that attacks infected cells) more than doubled at the high dose by 3 months.
Richie JP Jr, Nichenametla S, Neidig W, et al.
2016
In 15 people with mid-stage Parkinson's, a single 200 mg dose through the nose raised measured brain glutathione (by MRS, a type of brain scan). The glutathione-to-creatine ratio rose by roughly 269% at 45 minutes and stayed up for at least an hour (P<0.001).
Mischley LK, Conley KE, Shankland EG, et al.
2023
Reviews how glutathione protects cells. It neutralizes peroxides (damaging molecules) as a partner to glutathione peroxidase (an enzyme), cycling between GSH and GSSG (its active and used-up forms) with the help of glutathione reductase and NADPH. It tags toxins for removal through glutathione-S-transferase (an enzyme), and fine-tunes how proteins work through reversible S-glutathionylation (attaching and removing glutathione on proteins).
Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M
1997
In people with mild asthma, inhaled (nebulized) glutathione caused cough, breathlessness and measurable airway narrowing. The effect tracked with sulfite sensitivity, a warning that the inhaled route needs caution in asthma.
Marrades RM, Roca J, Barberà JA, et al.
1988
Traces glutathione's history: first seen in yeast by de Rey-Pailhade in 1888 (he called it philothion), extracted and named by F. Gowland Hopkins in 1921, and confirmed in 1929 as a tripeptide (a chain of three amino acids) of glutamate, cysteine and glycine.
Simoni RD, Hill RL, Vaughan M (historical review of Hopkins' work)
1993
In a placebo-controlled, double-blind crossover trial (neither patients nor doctors knew who got the drug, and each person tried both), glutathione given as 600 mg by intramuscular injection (into a muscle) every other day for 2 months significantly improved sperm motility and structure in men with infertility. This is peer-reviewed evidence that injected glutathione has measurable effects.
Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F
2014
In a double-blind, placebo-controlled split-face trial (each person's two face halves got different treatments) in 30 healthy women, a 2% oxidized glutathione (GSSG) lotion applied twice daily for 10 weeks significantly reduced the skin melanin index (a measure of skin darkness), giving a lighter skin tone, and improved the skin's moisture barrier, with no significant adverse effects.
Watanabe F, Hashizume E, Chan GP, Kamimura A
2015
In 30 people with Parkinson's randomized to placebo, 300 mg/day, or 600 mg/day of glutathione through the nose (divided into three daily doses) for 3 months, there were no substantial differences between groups in the number of adverse events, and all groups met the tolerability criteria.
Mischley LK, Leverenz JB, Lau RC, et al.